Literature DB >> 26879369

Erratum to: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer.

Kyung Ho Pak1,2, Dong Hoon Kim3, Hyunki Kim4, Do Hyung Lee5, Jae-Ho Cheong6,7,8,9.   

Abstract

Entities:  

Year:  2016        PMID： 26879369      PMCID： PMC4753667          DOI： 10.1186/s12885-016-2140-5

Source DB:  PubMed          Journal:  BMC Cancer        ISSN： 1471-2407            Impact factor:   4.430


× No keyword cloud information.

Erratum

Unfortunately, the original version of this article [1] contained an error in Fig. 2. Within this figure, the annotations for “High TGFb1” and “Low TGFb1” were the wrong way around. This has been corrected in the original article and is also included correctly below.
Fig. 2

ᅟ

ᅟ
  1 in total

1.  Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer.

Authors:  Kyung Ho Pak; Dong Hoon Kim; Hyunki Kim; Do Hyung Lee; Jae-Ho Cheong
Journal:  BMC Cancer       Date:  2016-02-04       Impact factor: 4.430
  1 in total
  1 in total

1.  Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-β/epithelial-mesenchymal transition signaling pathway.

Authors:  Chun-Ling Yuan; Rong Liang; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Yan Lin
Journal:  Exp Ther Med       Date:  2018-04-20       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.